Bausch Health CEO’s 2019 pay climbs to US$17.14-million [Toronto Globe and Mail (Ontario, Canada)]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Toronto Globe and Mail
Bausch Health CEO’s 2019 pay climbs to US$17.14-million Joseph Papa's pay jump was driven by stock and option awards worth nearly US$12.3-million. CHRISTINNE MUSCHI/REUTERS Joseph Papa's pay jump was driven by stock and option awards worth nearly US$12.3-million. Bausch Health Cos. Inc. – once known as Valeant Pharmaceuticals – paid chief executive officer Joseph Papa US$17.14-million in 2019, up from US$14.74-million the year before. The pay jump was driven by stock and option awards worth nearly US$12.3-million. Those awards can ultimately pay Mr. Papa more – or less – depending on how the company’s shares perform. Stock-based pay has been a big part of executive compensation for Bausch, which hired Mr. Papa in 2016 to turn the company around. At one point, Valeant, based in Laval, Que., was the most valuable company on the Toronto Stock Exchange under former CEO Michael Pearson. But investors soured on the company’s debt-heavy, growth-through-acquisition model. Mr. Papa, based i
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch & Lomb Corporation (BLCO)-A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]Yahoo! Finance
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]Yahoo! Finance
- Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of CirrhosisAccesswire
- PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSSAccesswire
BHC
Earnings
- 10/30/24 - Miss
BHC
Sec Filings
- 11/1/24 - Form 8-K
- 10/31/24 - Form 10-Q
- 10/30/24 - Form 8-K
- BHC's page on the SEC website